Riskpilot← Back to searchSign inGet full accessRAKKESTAD DYREKLINIKK AS
ASActiveOrg 926585134Industriveien 4, 1890 RakkestadVeterinary activities · NACE 7500Est. 20216 employees
Revenue 2025
NOK 8,7M
+19% vs 2024
EBITDA margin
21.1%
+75% vs 2024
Equity ratio
70.2%
Financial strength
Net profit 2025
NOK 1,4M
+86% vs 2024
| Revenue | NOK 8,7M | +19% |
| EBITDA | NOK 1,8M | +75% |
| Net profit | NOK 1,4M | +86% |
| Total assets | NOK 5,6M | +40% |
| Equity | NOK 3,9M | +49% |
| Employees | 6 | — |
Legal name
RAKKESTAD DYREKLINIKK AS
Org number
926585134
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
12. februar 2021
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Utøvelse av veterinærvirksomhet og relaterte tjenester, samt salg av dyrefor og andre virksomhetsrelaterte produkter og annet som naturlig faller sammen med dette.
Address
Industriveien 4, 1890 Rakkestad
Phone
+4769221090
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 610 | 5 426 | 6 750 | 7 352 | 8 721 |
| Staff expenses | −1 750 | −2 115 | −2 241 | −3 157 | −3 624 |
| EBITDA | 847 | 936 | 1 458 | 1 053 | 1 837 |
| Depreciation & amort. | −7 | −80 | −87 | −89 | −89 |
| EBIT | 840 | 855 | 1 371 | 963 | 1 748 |
| Net financials | −1 | 0 | 5 | 30 | 95 |
| Profit before tax | 840 | 856 | 1 375 | 994 | 1 843 |
| Tax | 185 | 188 | 222 | 219 | 405 |
| Net profit | 655 | 667 | 1 153 | 775 | 1 438 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 354 | 2 685 | 3 270 | 3 956 | 5 552 |
| Equity | 535 | 1 052 | 2 055 | 2 608 | 3 896 |
| Long-term debt | 34 | 51 | 52 | 53 | 0 |
| Short-term debt | 786 | 1 582 | 1 163 | 1 294 | 1 607 |
| Total debt | 820 | 1 633 | 1 215 | 1 348 | 1 656 |
EBITDA margin
21.1%
This company
15.8%
Market median
+34% vs market
20212025
Equity ratio
70.2%
This company
38.2%
Market median
+84% vs market
20212025
Return on equity
36.9%
This company
18.4%
Market median
+101% vs market
20212025
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
20212025
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20212025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RAKKESTAD DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per August Torp | Chief Executive Officer | 0 companies |
| Nina Gudim | Board of Directors | 0 companies |